Neuraxial block, death, and serious cardiovascular morbidity in the POISE trial Editor-I believe I am not alone in finding the study by Leslie and colleagues 1 of high interest. Many of us have wondered if the choice of anaesthesia, general vs neuraxial, had a significant effect on the outcomes observed in the POISE trial. 2 Let us recall that the POISE trial randomized b-blocker naive patients to either extended-release metoprolol (given immediately before surgery) or placebo. Thus, one can easily imagine a scenario where patients who just received a large dose of metoprolol and underwent subsequent neuraxial block could have developed clinically significant hypotension, and perhaps even adverse outcomes, such as stroke. I hoped that the current study by Leslie and colleagues would answer the question, if there is a clinically relevant interaction between metoprolol, neuraxial anaesthesia, and outcomes. Unfortunately, the article does not provide these important data. Given the importance of an improved understanding regarding the interaction between b-blockers and neuraxial anaesthesia, would it be possible for the authors to provide the readership with two new Tables 2 and 3 , stratified not just by neuraxial anaesthesia, but also by metoprolol administration? I understand that this request surmounts to a lot of extra work, but I believe it would offer very interesting insights.
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